ApopLogic Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of Breceptin, a unique oncolytic drug for the treatment of a wide range of solid tumors.
Company (Alive / Active)
12635 East Montview Blvd
Colorado, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)